NCT00043823View on ClinicalTrials.gov

Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

August 1, 2002

Primary Completion Date

May 15, 2006

Study Completion Date

May 15, 2006

Conditions
Lung Cancer
Interventions
DRUG

Avastin

7.5 mg/kg By Vein on Day 1 of Every 21 Day Cycle

DRUG

Tarceva

100 mg By Mouth Daily for 3 Weeks

Trial Locations (2)

37232

Vanderbilt-Ingram Cancer Center, Nashville

77030

University of Texas M.D. Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

collaborator

Vanderbilt-Ingram Cancer Center

OTHER

lead

M.D. Anderson Cancer Center

OTHER